Advanced Pancreatic Cancer Clinical Trials

64 clinical trials for Advanced Pancreatic Cancer across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer — RECRUITING · PHASE1
• Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases — RECRUITING · PHASE1
• Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients — RECRUITING · NA
• Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C — RECRUITING · PHASE1
• Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer — RECRUITING · PHASE2
• Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer. — RECRUITING · PHASE1
• Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV — RECRUITING · PHASE1
• A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer — RECRUITING · PHASE2
• Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer — RECRUITING · PHASE1
• Therapeutic targets in Pancreas — TERMINATED · PHASE2
• Phase I/II study of lenalidomide and gemcitabine as first-line treatment in patients with locally advanced or metastatic pancreatic cancer. — COMPLETED · PHASE2
• A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies — ACTIVE_NOT_RECRUITING · PHASE1
• 1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Gemcitabine plus nab-PAclitaxel as switch maiNTEnance versus cONtinuation of modified FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: the PANThEON phase III Trial. — TERMINATED · PHASE3
• TAILOR-PANC: Molecularly Tailored Therapy versus Standard Care in Advanced Pancreatic Cancer (DPCG-02) — NOT_YET_RECRUITING · PHASE2
• A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer — NOT_YET_RECRUITING · PHASE3
• A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• A Clinical Study Evaluating a New Treatment Strategy for Patients With Advanced Pancreatic Cancer Who Have Not Received Prior Treatment for Advanced Disease. — NOT_YET_RECRUITING · PHASE2
• ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies — COMPLETED · PHASE1
• Pancreatic Adenocarcinoma Signature Stratification for Treatment — COMPLETED · PHASE2
• APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma — TERMINATED · PHASE1
• Nivolumab With Ipilimumab Combined With TGFβ-15 Peptide Vaccine and Radiotherapy for Pancreatic Cancer (CheckVAC) — OTHER · PHASE1
• Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A Real-world Study of Liposomal Irinotecan (Onivyde)-Based Therapy in Patients With Locally Advanced/Metastatic Pancreatic Cancer in China — NOT_YET_RECRUITING
• A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced Pancreatic Cancer — TERMINATED · PHASE1
• Study to Evaluate the Safety and Efficacy of Treatment with NLM-001 before Standard Chemotherapy plus Zalifrelimab in Patients with Advanced Pancreatic Cancer — OTHER · PHASE1
• Statin Addition to Chemotherapy for Advanced Pancreatic Cancer — COMPLETED · PHASE2
• A Study of Irinotecan Liposome in Advanced Pancreatic Cancer — COMPLETED · PHASE1
• Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer — COMPLETED · PHASE1
• A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic Cancer — COMPLETED · PHASE1
• A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer — COMPLETED · PHASE2
• A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer — NOT_YET_RECRUITING · PHASE3
• SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer — OTHER · PHASE2
• A Phase II Study of Surufatinib Combined With Camrelizumab and mFOLFOX6 as Second-line Treatment for Advanced PRAD — NOT_YET_RECRUITING · PHASE2
• Olaparib in PALB2 Advanced Pancreatic Cancer — OTHER · PHASE2
• Paricalcitol Trial: Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic Cancer — COMPLETED · PHASE2
• IMC001 for Clinical Research on Advanced Digestive System Malignancies — OTHER · PHASE1
• Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer — OTHER · PHASE1
• Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer — OTHER · PHASE1
• A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer — COMPLETED · PHASE2
• Organoid-Guided Chemotherapy for Advanced Pancreatic Cancer — OTHER · PHASE3
• The Safety and Efficacy of Specific TIL-TCM Cells for Advanced Relapse-refractory or Metastatic Pancreatic Cancer — OTHER · PHASE1
• Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer — OTHER · PHASE2
• Clinical Study of VG161 in Combination With Nivolumab in Subjects With Advanced Pancreatic Cancer — OTHER · PHASE1
• A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer — COMPLETED · PHASE2
• A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic Cancer — OTHER · PHASE2
• Web-based Treatment Information Tool for People With Advanced Pancreatic Cancer — COMPLETED
• A Trial of SHR-A1904 in Patients With Advanced Pancreatic Cancer — OTHER · PHASE1
• Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer — COMPLETED · PHASE2
• Ntraperitoneal Thermal Perfusion Combined With Chemotherapy Versus Chemotherapy — OTHER · PHASE1

Refine this search